| Name | Title | Contact Details |
|---|
Located in northern California, Consensus Orthopedics is committed to providing proven and reliable total joint implants and instruments to the global market. Consensus headquarters include administrative offices, research and design workrooms, manufacturing, inspection, clean room and warehouse space. With over 25 years of orthopedic design and manufacturing experience, together, through a focus on patient care and clinician relationships, Consensus is dedicated to creating one team, focused on restoring mobility and renewing lives.
Neometrics Inc is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
The company is focused on establishing a new standard of care for women with symptomatic uterine fibroids. The Acessa System is cleared by the FDA and has CE mark for use in percutaneous, laparoscopic coagulation and ablation of soft tissue, including treatment of symptomatic uterine fibroids under laparoscopic ultrasound guidance. The Company is located in Austin, TX.
Grand X-Ray Instrumentarium Imaging is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company`s CorPath® System is the first FDA-cleared medical device to bring robotic-assisted precision to radial, coronary and peripheral procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance stents and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to radial and complex interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures. Corindus stands behind its product with its unique $1,000 hospital credit "One Stent Program."